14848-54-5 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-chloropropyl)-3-cyclohexylurea is used as an intermediate in the synthesis of other organic compounds, particularly in the development of new pharmaceuticals. Its unique structure allows for the creation of diverse drug candidates with potential therapeutic benefits.
Used in Medicinal Chemistry Research and Development:
As a pharmacological agent, 1-(3-chloropropyl)-3-cyclohexylurea is utilized in research and development for its potential applications in medicinal chemistry. Its chemical structure and properties make it a valuable tool for exploring new therapeutic agents and understanding their mechanisms of action.
Used in Chemical Processes:
1-(3-chloropropyl)-3-cyclohexylurea's versatile chemical properties also make it useful in various chemical processes. Its cyclohexyl and 3-chloropropyl groups can participate in a range of reactions, enabling the synthesis of a wide array of compounds for different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 14848-54-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,8,4 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14848-54:
(7*1)+(6*4)+(5*8)+(4*4)+(3*8)+(2*5)+(1*4)=125
125 % 10 = 5
So 14848-54-5 is a valid CAS Registry Number.
14848-54-5Relevant academic research and scientific papers
Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase
Meirer, Karin,R?dl, Carmen B.,Wisniewska, Joanna M.,George, Sven,H?fner, Ann-Kathrin,Buscató, Estella,Klingler, Franca-Maria,Hahn, Steffen,Berressem, Dirk,Wittmann, Sandra K.,Steinhilber, Dieter,Hofmann, Bettina,Proschak, Ewgenij
supporting information, p. 1777 - 1781 (2013/03/29)
Current research leads to the assumption that drugs affecting more than one target could result in a more efficient treatment of diseases and fewer safety concerns. Administration of drugs inhibiting only one branch of the arachidonic acid cascade is usua
